Biofarmaceutisch onderzoek: Essentiële klinische studies

Biopharmaceutical studies aim to study drug delivery and improved therapies using interdisciplinary knowledge.

Non-controlled studies, often used for initial exploration, lack a control group, which can lead to biases and external influences.

Contrarily, controlled studies employ a control group and incorporate techniques such as placebo, historical, crossover, or standard treatment controls to reduce bias.

To further minimize bias, blinding keeps participants or investigators unaware of the assigned treatment. This includes single-blind, double-blind, and double-dummy studies.

Confounding, caused by external variables affecting the study's outcome, is mitigated through proper study design, methodology, and statistical analysis, and helps validate the study.

Internal validity addresses the quality of study execution, while external validity gauges the applicability of the findings to other populations.

In clinical studies, risk calculation estimates the exposure-outcome association. It encompasses measures like absolute and relative risks, absolute and relative risk reduction, treatment numbers, and hazards and odds ratio.